Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an ...

Recent research looked at the prevalence of E. coli and other pathogens on organically grown vegetables. The research team was concerned with poultry ...

Studying E. coli DNA, the researchers found that the DNA sequences Zur and ZntR recognize overlap partially, raising the question of whether they really can cross-interact. The experiment proving ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...

Escherichia coli bacteria imaged by high-speed inline force mapping and fluorescence microscopy. Simultaneous topography and elastic modulus maps show a stiffening of the division site. Light and ...

Escherichia coli, commonly known as E. coli, is a versatile bacterium. While many strains are harmless and a natural part of our intestinal ...

Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...